DLDCX
Price
$40.02
Change
-$0.45 (-1.11%)
Updated
Nov 13 closing price
Net Assets
975.77M
PRNEX
Price
$43.26
Change
-$0.43 (-0.98%)
Updated
Nov 13 closing price
Net Assets
2.5B
Interact to see
Advertisement

DLDCX vs PRNEX

Header iconDLDCX vs PRNEX Comparison
Open Charts DLDCX vs PRNEXBanner chart's image
BNY Mellon Natural Resources C
Price$40.02
Change-$0.45 (-1.11%)
VolumeN/A
Net Assets975.77M
T. Rowe Price New Era
Price$43.26
Change-$0.43 (-0.98%)
VolumeN/A
Net Assets2.5B
DLDCX vs PRNEX Comparison Chart in %
View a ticker or compare two or three
VS
DLDCX vs. PRNEX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DLDCX is a Buy and PRNEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PRNEX has more cash in the bank: 2.51B vs. DLDCX (976M). PRNEX pays higher dividends than DLDCX: PRNEX (1.81) vs DLDCX (0.50). DLDCX was incepted earlier than PRNEX: DLDCX (22 years) vs PRNEX (57 years). DLDCX (1.87) is less costly to investors than PRNEX (0.77). DLDCX is a more actively managed with annual turnover of: 103.94 vs. PRNEX (24.30). DLDCX has a lower initial minimum investment than PRNEX: DLDCX (1000) vs PRNEX (2500). PRNEX annual gain was more profitable for investors over the last year : 7.19 vs. DLDCX (-5.24). DLDCX (60.22) and PRNEX (59.63) have equivalent 5 years return.
DLDCXPRNEXDLDCX / PRNEX
Total Expense Ratio1.870.77243%
Annual Report Gross Expense Ratio1.870.77243%
Fund Existence22 years57 years-
Gain YTD8.49917.57348%
Front LoadN/AN/A-
Min. Initial Investment1000250040%
Min. Initial Investment IRAN/AN/A-
Net Assets976M2.51B39%
Annual Yield % from dividends0.501.8128%
Returns for 1 year-5.247.19-73%
Returns for 3 years-23.947.57-316%
Returns for 5 years60.2259.63101%
Returns for 10 years93.4374.71125%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BLTE110.825.06
+4.78%
Belite Bio
NUE148.384.34
+3.01%
Nucor Corp
ABP6.030.05
+0.84%
Abpro Holdings Inc
SSYS9.540.02
+0.21%
Stratasys Ltd
HCAT2.46-0.23
-8.55%
Health Catalyst